Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2011 Financial Results
01. Februar 2012 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. Stayed
26. Januar 2012 13:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta to Host Investor Conference Call on December 23, 2011 to Discuss Follow-On Biologics Collaboration With Baxter
22. Dezember 2011 16:19 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 22, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals
05. Dezember 2011 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 5, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
TIME CHANGE: Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
01. Dezember 2011 14:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 1, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
28. November 2011 17:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011
07. November 2011 08:51 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
28. Oktober 2011 16:47 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms
24. Oktober 2011 17:13 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2011 Financial Results
24. Oktober 2011 10:45 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...